TY  - GEN
AU  - Örmeci,Necati
AU  - Sezgin,Orhan
AU  - Karaali,Ridvan
AU  - Aygen,Bilgehan
AU  - Turan,Dilara
AU  - Yaras,Serkan
AU  - Erdem,İlknur
AU  - Yildiz,Orhan
AU  - Karakaya,Fatih
AU  - Ateş,Kenan
AU  - Asiller,Özgün Ö
TI  - Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences
SN  - 1473-5687
PY  - 2019///0624
KW  - 2-Naphthylamine
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anilides
KW  - administration & dosage
KW  - Antiviral Agents
KW  - Carbamates
KW  - Cyclopropanes
KW  - Drug Therapy, Combination
KW  - Female
KW  - Hepacivirus
KW  - isolation & purification
KW  - Hepatitis C, Chronic
KW  - complications
KW  - Humans
KW  - Lactams, Macrocyclic
KW  - Macrocyclic Compounds
KW  - Male
KW  - Middle Aged
KW  - Proline
KW  - analogs & derivatives
KW  - Renal Insufficiency, Chronic
KW  - Retrospective Studies
KW  - Ritonavir
KW  - Sulfonamides
KW  - Sustained Virologic Response
KW  - Treatment Outcome
KW  - Uracil
KW  - Valine
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1097/MEG.0000000000001334
ER  -